We have moved to new location, Please click on contact us  
Home  >  News
you can get e-magazine links on WhatsApp. Click here
  Bioxytran gets CDSCO approval to initiate trials with ProLectin-I to treat Long Covid and idiopathic pulmonary fibrosis,   February 07, 2023
  Certa Therapeutics announces positive results from phase 2 scleroderma study,   February 07, 2023
  Daewoong Pharma begins patient dosing in phase II trial of Bersiporocin to treat idiopathic pulmonary fibrosis,   February 07, 2023
  Addex partner completes enrollment in ADX71149 epilepsy phase 2 study part 1,   February 07, 2023
  US FDA clears Accutar Biotechnology’s IND application for phase 1 trial of AC0676 in B-cell malignancies,   February 06, 2023
  EMA, HMA & EC launch public consultation on multi-stakeholder platform to improve clinical trials in EU,   February 06, 2023
  Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx,   February 06, 2023
  Aardex, Cambridge Cognition join forces to bring next-level adherence oversight to hybrid and decentralized clinical trials,   February 04, 2023
  Merck announces phase 3 NRG-GY018 trial of Keytruda plus chemotherapy to treat advanced or recurrent endometrial carcinoma meets primary endpoint,   February 04, 2023
  Biophytis releases final results from phase 2-3 COVA study evaluating Sarconeos in severe Covid-19,   February 03, 2023
  Agomab announces positive results from phase 1 study of AGMB-129 for treatment of fibrostenosing Crohn’s disease,   February 03, 2023
  Anaveon begins patient dosing in phase I/II study of ANV419 to treat advanced melanoma,   February 03, 2023
  Sirnaomics to speed up clinical development of STP705 to treat non-melanoma skin cancers,   February 02, 2023
  Use of CTIS becomes mandatory for new clinical trial applications in European Union,   February 02, 2023
  Sciwind Biosciences begins patient dosing in phase 3 trials of ecnoglutide to treat type 2 diabetes in China,   February 01, 2023
  Ascletis gets US FDA approval to conduct phase IIa trial of ASC10 to treat respiratory syncytial virus infection,   February 01, 2023
  Marburg vaccine shows promising results in first-in-human study,   February 01, 2023
  Daiichi Sankyo begins patient dosing in TROPION-Lung07 phase 3 trial to evaluate datopotamab deruxtecan in combo with pembrolizumab to treat patients with previously untreated metastatic NSCLC,   January 31, 2023
  Boehringer Ingelheim announces EFFISAYIL 2 of spesolimab meets primary and key secondary endpoint for prevention of generalized pustular psoriasis flares,   January 31, 2023
  Skye Bioscience receives Central IRB approval to begin phase 2 trial with SBI-100 ophthalmic emulsion,   January 30, 2023

India Lab Expo
Copyright © 2016 Saffron Media Pvt. Ltd |